Release Date: 24/02/15 09:22 Summary: SBN Invests In Technology Accelerator Program Price Sensitive: Yes Download Document 51.55KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%